Wellington Management Group
ALDX icon

Wellington Management Group’s Aldeyra Therapeutics ALDX Stock Holding History

Wellington Management Group’s Portfolio ALDX Stock Details ALDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$252K Sell
148,962
-29,889
-17% -$131K ﹤0.01% 1822
2025
Q4 		$926K Sell
178,851
-10,970
-6% -$56.4K ﹤0.01% 1727
2025
Q3 		$991K Buy
+189,821
New +$990K ﹤0.01% 1783
2025
Q2 		– Sell
-117,475
Closed -$675K – 1935
2025
Q1 		$675K Buy
+117,475
New +$694K ﹤0.01% 1779

Other funds holding ALDX

KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Wellington Management Group's ALDX Position: Q1 2026 in Review

Wellington Management Group reduced its Aldeyra Therapeutics (ALDX) stake by 17% in Q1 2026, selling an estimated $131K and leaving 148,962 shares worth $252K. The position accounts for ﹤0.01% of the portfolio, ranked #1822.

Wellington Management Group first reported a position in ALDX in Q1 2025 and has held it in 4 quarters since. The position peaked at $991K in Q3 2025. 126 funds tracked by Wall St. Rank hold ALDX as of Q1 2026.

  • Wellington Management Group held 148,962 shares of Aldeyra Therapeutics worth $252K as of Q1 2026.
  • Wellington Management Group sold 29,889 Aldeyra Therapeutics shares in Q1 2026, an estimated $131K.
  • Aldeyra Therapeutics made up ﹤0.01% of Wellington Management Group's portfolio in Q1 2026, its #1822 holding.
  • Wellington Management Group first reported a position in Aldeyra Therapeutics in Q1 2025 and has held it in 4 quarters since.
  • Wellington Management Group's Aldeyra Therapeutics position peaked at $991K in Q3 2025.
  • 126 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q1 2026.

Based on Wellington Management Group's 13F filing for Q1 2026, filed 15 May 2026.